United Kingdom
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
USD 201.21 B |
Jan. 14, 2025 | USD 129.77 | -1.69% |
|
United Kingdom |
|
2 |
USD 64.43 B |
Jan. 14, 2025 | USD 15.79 | -2.73% |
|
United Kingdom |
|
3 |
USD 40.53 B |
Jan. 14, 2025 | USD 4.48 | -0.21% |
|
United Kingdom |
|
4 |
USD 12.26 B |
Jan. 14, 2025 | USD 32.51 | 0.69% |
|
United Kingdom |
|
5 |
USD 10.41 B |
Jan. 14, 2025 | USD 11.94 | -0.50% |
|
United Kingdom |
|
6 |
USD 7.96 B |
Jan. 14, 2025 | USD 10.94 | 1.86% |
|
United Kingdom |
|
7 |
USD 5.73 B |
Jan. 14, 2025 | USD 2.80 | 1.24% |
|
United Kingdom |
|
8 |
USD 5.42 B |
Jan. 14, 2025 | USD 24.44 | -0.21% |
|
United Kingdom |
|
9 |
USD 3.96 B |
Jan. 14, 2025 | USD 48.44 | 3.75% |
|
United Kingdom |
|
10 |
USD 3.57 B |
Jan. 14, 2025 | USD 5.03 | -1.57% |
|
United Kingdom |
|
11 |
USD 3.09 B |
Jan. 14, 2025 | USD 31.30 | -0.30% |
|
United Kingdom |
|
12 |
USD 2.89 B |
Jan. 14, 2025 | USD 39.68 | -1.13% |
|
United Kingdom |
|
13 |
USD 2.59 B |
Jan. 14, 2025 | USD 47.63 | 0.66% |
|
United Kingdom |
|
14 |
USD 1.96 B |
Jan. 14, 2025 | USD 14.84 | -2.75% |
|
United Kingdom |
|
15 |
USD 1.65 B |
Jan. 14, 2025 | USD 1.73 | -0.82% |
|
United Kingdom |
|
16 |
USD 1.43 B |
Jan. 14, 2025 | USD 28.56 | -4.90% |
|
United Kingdom |
|
17 |
USD 1.41 B |
Jan. 14, 2025 | USD 1.06 | 0.55% |
|
United Kingdom |
|
18 |
USD 1.39 B |
Jan. 14, 2025 | USD 23.93 | 0.29% |
|
United Kingdom |
|
19 |
USD 1.31 B |
Jan. 14, 2025 | USD 3.36 | 0.90% |
|
United Kingdom |
|
20 |
USD 1.14 B |
Jan. 14, 2025 | USD 17.38 | -3.70% |
|
United Kingdom |
|
21 |
USD 1.12 B |
Jan. 14, 2025 | USD 2.78 | 0.97% |
|
United Kingdom |
|
22 |
USD 1.02 B |
Jan. 14, 2025 | USD 14.81 | -2.31% |
|
United Kingdom |
|
23 |
USD 716.39 M |
Jan. 14, 2025 | USD 9.99 | -0.88% |
|
United Kingdom |
|
24 |
USD 608.17 M |
Jan. 14, 2025 | USD 91.56 | -0.71% |
|
United Kingdom |
|
25 |
USD 588.13 M |
Jan. 14, 2025 | USD 2.21 | -3.91% |
|
United Kingdom |
|
26 |
USD 571.28 M |
Jan. 14, 2025 | USD 2.66 | 14.48% |
|
United Kingdom |
|
27 |
USD 507.07 M |
Jan. 14, 2025 | USD 4.79 | -4.31% |
|
United Kingdom |
|
28 |
USD 474.75 M |
Jan. 14, 2025 | USD 3.06 | -8.38% |
|
United Kingdom |
|
29 |
USD 438.80 M |
Jan. 14, 2025 | USD 0.09 | 2.54% |
|
United Kingdom |
|
30 |
USD 403.20 M |
Jan. 14, 2025 | USD 0.75 | -0.07% |
|
United Kingdom |
|
31 |
USD 322.70 M |
Jan. 14, 2025 | USD 1.81 | 4.74% |
|
United Kingdom |
|
32 |
USD 310.58 M |
Jan. 14, 2025 | USD 3.36 | -0.30% |
|
United Kingdom |
|
33 |
USD 305.48 M |
Jan. 14, 2025 | USD 72.03 | -1.91% |
|
United Kingdom |
|
34 |
USD 264.88 M |
Jan. 14, 2025 | USD 5.61 | -4.92% |
|
United Kingdom |
|
35 |
USD 253.90 M |
Jan. 14, 2025 | USD 5.68 | 0.09% |
|
United Kingdom |
|
36 |
USD 237.56 M |
Jan. 14, 2025 | USD 4.76 | -2.41% |
|
United Kingdom |
|
37 |
USD 236.18 M |
Jan. 14, 2025 | USD 15.26 | 0.09% |
|
United Kingdom |
|
38 |
USD 225.96 M |
Jan. 14, 2025 | USD 0.62 | -2.80% |
|
United Kingdom |
|
39 |
USD 212.06 M |
Jan. 14, 2025 | USD 39.06 | 2.49% |
|
United Kingdom |
|
40 |
USD 205.44 M |
Jan. 14, 2025 | USD 2.92 | -0.33% |
|
United Kingdom |
|
41 |
USD 146.78 M |
Jan. 14, 2025 | USD 0.31 | 0.09% |
|
United Kingdom |
|
42 |
USD 145.35 M |
Jan. 14, 2025 | USD 0.21 | 6.16% |
|
United Kingdom |
|
43 |
USD 116.65 M |
Jan. 14, 2025 | USD 2.90 | -3.96% |
|
United Kingdom |
|
44 |
USD 116.44 M |
Jan. 14, 2025 | USD 0.11 | -4.08% |
|
United Kingdom |
|
45 |
USD 111.23 M |
Jan. 14, 2025 | USD 0.37 | -1.16% |
|
United Kingdom |
|
46 |
USD 93.08 M |
Jan. 14, 2025 | USD 0.23 | 1.46% |
|
United Kingdom |
|
47 |
USD 81.85 M |
Jan. 14, 2025 | USD 2.20 | 0.09% |
|
United Kingdom |
|
48 |
USD 73.07 M |
Jan. 14, 2025 | USD 0.32 | 0.09% |
|
United Kingdom |
|
49 |
USD 67.13 M |
Jan. 14, 2025 | USD 0.64 | 0.47% |
|
United Kingdom |
|
50 |
USD 58.16 M |
Jan. 14, 2025 | USD 0.46 | 0.09% |
|
United Kingdom |
The Health Care company in United Kingdom with the highest Market Capitalization is AstraZeneca PLC (LSE: AZN.L) at USD 201.21 B.
The Health Care company in United Kingdom with the lowest Market Capitalization is Akanda Corp. (NasdaqCM: AKAN) at USD 2.18 M.
The top 10 Health Care companies in United Kingdom by Market Capitalization are AstraZeneca PLC, GSK plc, Haleon plc, Halma plc, Smith & Nephew plc, Roivant Sciences Ltd., ConvaTec Group Plc, Hikma Pharmaceuticals PLC, Verona Pharma plc and Clarivate Plc.
The bottom 10 Health Care companies in United Kingdom by Market Capitalization are Akanda Corp., Biome Technologies plc, Oxford BioDynamics Plc, Biodexa Pharmaceuticals Plc, NuCana plc, Image Scan Holdings Plc, Roquefort Therapeutics plc, GENinCode plc, Synairgen plc and Genflow Biosciences plc.